| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
KS176
|
1253452-78-6 |
KS176
|
KS-176;KS 176;CS-2318
|
C22H19N3O5 |
405.41 | |
|
NSC59984
|
803647-40-7 |
1G,1G,1G,1KG
|
1G,10G,100G,1KG;NSC-59984;NSC 59984;CS-2317;1-(4-甲基-1-哌嗪基)-3-(5-硝基-2-呋喃基)-2-丙烯-1-酮
|
C12H15N3O4 |
265.2652 | |
|
PD-168393
|
194423-15-9 |
PD168393
|
PD168393;PD-168393;PD 168393;N-[4-[(3-溴苯基)氨基]-6-喹唑啉基]-2-丙烯酰胺;CS-2316;PD-168393;PD 168393;N-[4-[(3-溴苯基)氨基]-6-喹唑啉]-2-丙酰胺
|
C17H13BrN4O |
369.22 | |
|
AAL-993
|
269390-77-4 |
AAL-993
|
CS-2315
|
C20H16F3N3O |
371.36522 | |
|
2-Chloro-5-nitro-N-4-pyridinylbenzamide
|
313516-66-4 |
T797
|
2-氯-5-硝基-N-4-吡啶基苯甲酰胺;苯甲酰胺,2-氯-5-硝基-N-4-吡啶基-;2-氯-5-硝基-N-4-吡啶苯甲酰胺;2-氯-5-硝基-N-(吡啶-4-基)苯甲酰胺
|
C12H8ClN3O3 |
277.66 | |
|
YYA-021
|
144217-65-2 |
YYA-21
|
6-四甲基哌啶-4-基)草酰胺;N-(4-甲基苯基)-N'-(2;CS-2313;N-(4-甲基苯基)-N'-(2,2,6,6-四甲基哌啶-4-基)草酰胺
|
C18H27N3O2 |
317.42588 | |
|
C-DIM12
|
178946-89-9 |
C-DIM12
|
C-DIM12>98%;CS-2311
|
C23H17ClN2 |
356.84748 | |
|
PBTZ169
|
1377239-83-2 |
PBTZ169
|
CS-2309;MACOZINONE;PBTZ169;PBTZ-169;PBTZ 169;2-(4-(环己基甲基)哌嗪-1-基)-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮
|
C20H23F3N4O3S |
456.48183 | |
|
SMER28
|
307538-42-7 |
SMER28
|
SMER 28;SMER28 - CAS 307538-42-7 - Calbiochem;6-Bromo-N-prop-2-enylquinazolin-4-amine;6-BroMo-N-2-propen-1-yl-4-quinazolinaMine;6-BroMo-N-2-propenyl-4-QuinazolinaMine
|
C11H10BrN3 |
264.1212 | |
|
MP-412
|
451492-95-8 |
AV-412
|
CS-2307;N-[4-[(3-氯-4-氟苯基)氨基]-7-[3-甲基-3-(4-甲基-1-哌嗪基)-1-丁炔-1-基]-6-喹唑啉基]-2-丙烯酰胺;AV-412;MP-412;AV 412;MP 412;AV412;MP412
|
C27H28ClFN6O |
507.02 | |
|
SW044248
|
522650-83-5 |
SW-44248
|
2-[(5-乙基-5H-1,2,4-三嗪并[5,6-B]吲哚-3-基)硫基]-N-(2-甲氧基苯基)丁酰胺
|
C22H23N5O2S |
421.51532 | |
|
BML-210
|
537034-17-6 |
CAY1433
|
BML210;BML 210;CAY10433;CAY-10433;CAY 10433;N1-(2-氨基苯基(-N8-苯基辛烷二酰胺;CS-2301;BML210>98%
|
C20H25N3O2 |
339.43 | |
|
BQU 57
|
1637739-82-2 |
BQU57
|
|
C16H13F3N4O |
334.29583 | |
|
Coelenterazine
|
55779-48-1 |
腔肠素
|
香菇碱杂质;CS-2297;2-[(4-羟基苯基)甲基]-6-(4-羟基苯基)-8-(苯基甲基)-咪唑并[1,2-a]吡嗪-3-(7H)-酮;腔肠素;2-[(4-羟基苯基)甲基]-6-(4-羟基苯基)-8-苄基-咪唑并[1,2-a]吡嗪-3-(7H)-酮;8-苄基-2-(4-羟基苯基)-6-(4-羟基苯基)-咪唑并[1,2-A]吡嗪-3-(7H)-酮
|
C26H21N3O3 |
423.46 | |
|
SD-208
|
627536-09-8 |
SD-28
|
2-(5-氯-2-氟苯基)-N-4-吡啶基-4-蝶啶胺;SD-208;SD 208;SD208;SCI 208;CS-2295;SD 208;SD208;TGF-Β RI KINASE INHIBITOR V;SD-208 10MG;2-(5-氯-2-氟苯基)-4-[(4-吡啶基)氨基]蝶啶
|
C17H10ClFN6 |
352.752903 | |
|
Vipadenant
|
442908-10-3 |
维帕地南
|
3-(4-氨基-3-甲基并苄基)-7-(2-呋喃基)-3H-[1,2,3]噻唑并[4,5-D]嘧啶-5-胺;3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,3]三唑并[4,5-D]嘧啶-5-胺;CS-2294;BIIB-014;BIIB 014;BIIB014
|
C16H15N7O |
321.3366 | |
|
SRT2104 (GSK2245840)
|
1093403-33-8 |
SRT214 (GSK224584)
|
SRT-2104;SRT 2104;4-甲基-N-[2-[3-(吗啉基甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-(吡啶-3-基)噻唑-5-甲酰胺;CS-2293;SRT 2104 选择性SIRT1活化剂
|
C26H24N6O2S2 |
516.63776 | |
|
EW-7197
|
1352608-82-2 |
EW-7197
|
EW-7197;EW 7197;EW7197;TEW-7197;NOV-1301;EW-7197;CS-2287;CS-2288;N-[[4-([1,2,4]三唑并[1,5-A]吡啶-6-基)-5-(6-甲基吡啶-2-基)-1H-咪唑-2-基]甲基]-2-氟苯胺;CPD3325
|
C22H18FN7 |
399.43 | |
|
(E)-3-(3-bromo-4,5-dihydroxyphenyl)-N-(3,4,5-trihydroxybenzyl)prop-2-enethioamide
|
1384426-12-3 |
NT-157
|
NT-157;NT 157;TYRPHOSTIN NT157;NT-157;(E)-3-(3-溴-4,5-二羟苯基)-N-(3,4,5-三羟基苄基)丙-2-烯硫代酰胺;CS-2283;NT157;NT 157;(2E)-3-(3-溴-4,5-二羟基苯基)-N-[(3,5-三羟基苯基)甲基]-2-硫代丙烯酰胺
|
C16H14BrNO5S |
412.25506 | |
|
ACT-678689
|
1783256-96-1 |
ACT-678689
|
ACT-678689
|
药智官方微信
药智官方微博
